FDA Inspection 1149072 — Alfred A. Lardizabal, MD

Alfred A. Lardizabal, MD — FEI 3015969066

The FDA completed an inspection of Alfred A. Lardizabal, MD on Jul 13, 2021 in Newark, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jul 13, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Newark, NJ (United States)

Additional details

Sponsor-Investigator (S-I)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.